医学
按摩
缓和医疗
睡眠障碍
随机对照试验
物理疗法
内科学
优势比
癌症
失眠症
护理部
病理
替代医学
精神科
作者
Mojtaba Miladinia,Mina Jahangiri,Ann Blair Kennedy,Cecilia Fagerström,Hanna Tuvesson,Shadi Sadat Safavi,Mahmood Maniati,Fatemeh Javaherforooshzadeh,Hossein Karimpourian
标识
DOI:10.1177/02692163221129158
摘要
The efficacy of various massage doses in palliative cancer care settings is still debated, and no specific protocol is available.Evaluating response to various massage doses for symptom cluster of pain-fatigue-sleep.A 7-arm randomized-controlled trial with weekly massage for 4 weeks depending on the prescribed dose (15-, 30-, or 60-min; 2× or 3×/week) and a 4-week follow-up. The intensities of pain, fatigue, and sleep disturbance were measured using a 0-10 scale at nine-timepoint; baseline, weekly during the intervention, and the follow-up period. Then, the mean scores of the three symptoms were calculated as the symptom cluster intensity at each timepoint. IRCT.ir IRCT20150302021307N5.Adults with cancer (n = 273) who reported all three symptoms at three oncology centers in Iran.The odds of clinical improvement (at least 30% reduction in symptom cluster intensity from baseline) increased with dose-escalation significantly [(OR = 17.37; 95% CI = 3.87-77.90 for 60-min doses); (OR = 11.71; 95% CI = 2.60-52.69, for 30-min doses); (OR = 4.36; 95% CI = 0.94-20.32, for 15-min doses)]. The effect durability was significantly shorter at 15-min doses compared to 30- and 60-min doses. The odds of improvement for doses 3×/week was not significant compared to doses 2×/week (OR = 12.27 vs OR = 8.34); however, the effect durability for doses 3×/week was significantly higher.The findings indicated that dose-escalation increases the efficacy of massage for the pain-fatigue-sleep symptom cluster. Although the 60-min doses were found to be more effective, the 30-min doses can be considered more practical because they are less costly and time-consuming. Our findings can be helpful to develop massage guidelines in palliative care settings.Iranian Registry of Clinical Trials, IRCT20150302021307N5.
科研通智能强力驱动
Strongly Powered by AbleSci AI